Article Figures & Data
Figures
- FIGURE 1.
Reported pain before and after treatment.
- FIGURE 2.
Scintigraphic images of chest and axilla in control group. ANT = anterior; BL = blocker present; BLKR = blocker present; LAT = lateral; TRANS = transverse.
- FIGURE 3.
Scintigraphic images of chest and axilla in experimental group. ANT= anterior; LAT = lateral.
Tables
Gradation Descriptor 0 No pain 1–3 Mild pain (nagging, annoying, interfering little with ADLs) 4–6 Moderate pain (interferes significantly with ADLs) 7–10 Severe pain (disabling; unable to perform ADLs) ADLs = activities of daily living.
Characteristic All Control group Experimental group Female patients (n) 49 24 (49%) 25 (51%) Age Range (y) 34–87 44–83 34–87 Mean (y) 61.4 59 64 Mean blood pressure (systolic/diastolic) (mm/hg) 162/82 177/81 148/83 Mean heart rate (beats per min) 79 77 80 Tumor grade* 1.8 1.6 2.0 Tumor size (cm) Range 0.4–12 0.4–12 0.4–4.0 Mean 1.8 2.1 1.5 Total volume injected (SC and lidocaine if administered) 3.61 1.1 6.2 ↵* Ductal carcinoma in situ considered grade 0.
- TABLE 3
Results: Control Versus Experimental Group Pain Experience Based on NIH Pain Scale of 0–10
NIH pain scale All Control group Experimental group Baseline Range 0–5 0–1 0–5 Mean 0.3 0.1 0.4 Peak Range 0–10 1–10 0–9 Mean 4.1 5.2 3.0 Mean increase in pain +3.8 +5.1 +2.6 Node detection characteristic All Control group Experimental group Patients with 1 or more axillary node detected 37 19 18 Patients without axillary nodes detected 12 5 7 Mean no. of axillary nodes detected 1.2 1.2 1.3 Imaging time (min) Mean 34 34 33 Range 6–62 25–62 6–59
